Abstract:Background: In low-risk pregnancies, a third-trimester ultrasound examination is indicated if fundal height measurement and gestational age discrepancy are observed. Despite potential improvement in the detection of ultrasound abnormality, prior trials to date on universal third-trimester ultrasound examination in low-risk pregnancies, compared with indicated ultrasound examination, have not demonstrated improvement in neonatal or maternal adverse outcomes. Objective: The primary objective was to determine if universal third-trimester ultrasound examination in low-risk pregnancies could attenuate composite neonatal adverse outcomes. The secondary objectives were to compare changes in composite maternal adverse outcomes and detection of abnormalities of fetal growth (fetal growth restriction or large for gestational age) or amniotic fluid (oligohydramnios or polyhydramnios). Study design: Our pre-post intervention study at 9 locations included low-risk pregnancies, those without indication for ultrasound examination in the third trimester. Compared with indicated ultrasound in the preimplementation period, in the postimplementation period, all patients were scheduled for ultrasound examination at 36.0-37.6 weeks. In both periods, clinicians intervened on the basis of abnormalities identified. Composite neonatal adverse outcomes included any of: Apgar score ≤5 at 5 minutes, cord pH <7.00, birth trauma (bone fracture or brachial plexus palsy), intubation for >24 hours, hypoxic-ischemic encephalopathy, seizure, sepsis (bacteremia proven with blood culture), meconium aspiration syndrome, intraventricular hemorrhage grade III or IV, periventricular leukomalacia, necrotizing enterocolitis, stillbirth after 36 weeks, or neonatal death within 28 days of birth. Composite maternal adverse outcomes included any of the following: chorioamnionitis, wound infection, estimated blood loss >1000 mL, blood transfusion, deep venous thrombus or pulmonary embolism, admission to intensive care unit, or death. Using Bayesian statistics, we calculated a sample size of 600 individuals in each arm to detect >75% probability of any reduction in primary outcome (80% power; 50% hypothesized risk reduction). Results: During the preintervention phase, 747 individuals were identified during the initial ultrasound examination, and among them, 568 (76.0%) met the inclusion criteria at 36.0-37.6 weeks; during the postintervention period, the corresponding numbers were 770 and 661 (85.8%). The rate of identified abnormalities of fetal growth or amniotic fluid increased from between the pre-post intervention period (7.1% vs 22.2%; P<.0001; number needed to diagnose, 7; 95% confidence interval, 5-9). The primary outcome occurred in 15 of 568 (2.6%) individuals in the preintervention and 12 of 661 (1.8%) in the postintervention group (83% probability of risk reduction; posterior relative risk, 0.69 [95% credible interval, 0.34-1.42]). The composite maternal adverse outcomes occurred in 8.6% in the preintervention and 6.5% in the postintervention group (90% probability of risk; posterior relative risk, 0.74 [95% credible interval, 0.49-1.15]). The number needed to treat to reduce composite neonatal adverse outcomes was 121 (95% confidence interval, 40-200). In addition, the number to reduce composite maternal adverse outcomes was 46 (95% confidence interval, 19-74), whereas the number to prevent cesarean delivery was 18 (95% confidence interval, 9-31). Conclusion: Among low-risk pregnancies, compared with routine care with indicated ultrasound examination, implementation of a universal third-trimester ultrasound examination at 36.0-37.6 weeks attenuated composite neonatal and maternal adverse outcomes.

ISUOG Practice Guidelines: performance of third‐trimester obstetric ultrasound scan

EP18.05: First trimester referral ultrasound following the introduction of the guidelines of the SIEOG: focus on false positives and false negatives

Impact of Unicornuate Uterus on Third-Trimester Obstetric Outcomes in Nulliparous Women

ISUOG Practice Guidelines (updated): use of Doppler velocimetry in obstetrics

Intrapartum Ultrasound Guidance to Make Safer Any Obstetric Intervention: Fetal Head Rotation, Assisted Vaginal Birth, Breech Delivery of the Second Twin

EP18.29: First trimester screening at conditions of limited resources

Ultrasound in labor: clinical practice guideline and recommendation by the WAPM-World Association of Perinatal Medicine and the PMF-Perinatal Medicine Foundation

Implementation of sonopartogram: multicenter feasibility study

OC03.01: Fetal lower urinary tract obstruction: international Delphi consensus on management and core outcomes set

Indicated vs universal third-trimester ultrasound examination in low-risk pregnancies: a pre-post-intervention study

Society of Obstetricians and Gynecologists Pakistan Guideline on Second Trimester Anomaly Scan Published in year 2022

EP25.18: Ultrasound screening of Müllerian anomalies

Current practice of ultrasound in the management of postpartum hemorrhage: a secondary analysis of a national survey

EP01.58: Which maternal and pregnancy characteristics affect obstetric ultrasound quality?

Mastering nonobstetric surgery in pregnancy: Insights, guidelines evaluation, and point‐by‐point discussion

EP19.12: A national survey on current practice of ultrasound in the management of postpartum hemorrhage

OP14.08: The role of three‐dimensional ultrasound in the evaluation of urogenital prolapse: a prospective study of 20 patients

EP25.03: The role of transabdominal 3D ultrasound in the diagnostic of congenital malformations of the reproductive system in pediatric and adolescent patients

OP05.08: The introduction of a fetal growth decision‐tool to improve consistency in management of ultrasound findings in late pregnancy

OP03.03: Role of artificial intelligence applied to ultrasound in gynecology oncology: a systematic review

The role of point-of-care ultrasound to monitor response of fluid replacement therapy in pregnancy